Clinical Trial Update: Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression [Phase 3]

View source ↗

Summary

Phase 3 study comparing duloxetine to escitalopram and placebo in patients with depression; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)
• Escitalopram (escitalopram)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depression | Phase 3 | Status: COMPLETED